Evidence map›Paper›PMID 29399293›Full record

ArticleNutrition research and practice2018

Anti-hyperglycemic effects and signaling mechanism of

Da-Hye Kim, Sang Jun Kim, Kang-Yeol Yu, Seung-Il Jeong, Seon-Young Kim

Open access · hybridAbstract read
In one paragraph

Article in Nutrition research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Comprehensive Review ofFoods (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Nutrients · 2019
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Da-Hye KimJeonju AgroBio-Materials Institute, 111-27, Wonjangdong-gil, Deokjin-gu, Jeonju, Jeonbuk 54810, Korea.
Sang Jun KimJeonju AgroBio-Materials Institute, 111-27, Wonjangdong-gil, Deokjin-gu, Jeonju, Jeonbuk 54810, Korea.
Kang-Yeol YuJeonju AgroBio-Materials Institute, 111-27, Wonjangdong-gil, Deokjin-gu, Jeonju, Jeonbuk 54810, Korea.
Seung-Il JeongJeonju AgroBio-Materials Institute, 111-27, Wonjangdong-gil, Deokjin-gu, Jeonju, Jeonbuk 54810, Korea.
Seon-Young KimJeonju AgroBio-Materials Institute, 111-27, Wonjangdong-gil, Deokjin-gu, Jeonju, Jeonbuk 54810, Korea.
Jeonbuk State Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesMATERIALS/

methodsMale db/db mice were orally administered PF sprout extract (100, 300, and 1,000 mg/kg of body weight) or rosiglitazone (RGZ, positive drug, 1 mg/kg of body weight) for 4 weeks. Signaling mechanisms were analyzed using liver tissues and HepG2 cells.

resultsThe PF sprout extract (300 and 1,000 mg/kg) significantly reduced the fasting blood glucose, serum insulin, triglyceride and total cholesterol levels in db/db mice. PF sprout extract also significantly improved glucose intolerance and insulin sensitivity, decreased hepatic gluconeogenic protein expression, and ameliorated histological alterations of the pancreas and liver. Levels of phosphorylated AMP-activated protein kinase (AMPK) protein expression also increased in the liver after treatment with the extract. In addition, an increase in the phosphorylation of AMPK and decrease in the phosphoenolpyruvate carboxykinase and glucose 6-phosphatase proteins in HepG2 cells were also observed.

conclusionsOur results sugges that PF sprout displays beneficial effects in the prevention and treatment of type 2 diabetes via modulation of the AMPK pathway and inhibition of gluconeogenesis in the liver.

Indexed as

diabetes mellitusgluconeogenesisPerilla frutescens

Identifiers

PMID29399293
PMCPMC5792252
OpenAlexW2785854287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.